129 related articles for article (PubMed ID: 34594933)
1. Epidemiological Characteristics of Rifampicin-Resistant Tuberculosis in Students - China, 2015-2019.
Su W; Ruan Y; Li T; Du X; Jiang J; He Y; Li R
China CDC Wkly; 2021 Jun; 3(26):549-552. PubMed ID: 34594933
[No Abstract] [Full Text] [Related]
2. Characteristics of rifampicin-resistant tuberculosis detection in China, 2015-2019.
Su W; Ruan YZ; Li T; Du X; Jiang JW; Li RZ
Infect Dis Poverty; 2021 Jul; 10(1):99. PubMed ID: 34274020
[TBL] [Abstract][Full Text] [Related]
3. Epidemiological profile of patients with rifampicin-resistant tuberculosis: an analysis of the Uganda National Tuberculosis Reference Laboratory Surveillance Data, 2014-2018.
Bahizi G; Majwala RK; Kisaka S; Nyombi A; Musisi K; Kwesiga B; Bulage L; Ario AR; Turyahabwe S
Antimicrob Resist Infect Control; 2021 May; 10(1):76. PubMed ID: 33964986
[TBL] [Abstract][Full Text] [Related]
4. Factors contributing to the high prevalence of multidrug-resistance/Rifampicin-resistance in patients with tuberculosis: an epidemiological cross sectional and qualitative study from Khabarovsk krai region of Russia.
Bykov I; Dyachenko O; Ratmanov P; Liu H; Liang L; Wu Q
BMC Infect Dis; 2022 Jul; 22(1):612. PubMed ID: 35831812
[TBL] [Abstract][Full Text] [Related]
5. Longitudinal Analysis of Prevalence and Risk Factors of Rifampicin-Resistant Tuberculosis in Zhejiang, China.
Liu Z; Zhang M; Wang J; Chen S; Wu B; Zhou L; Pan A; Wang W; Wang X
Biomed Res Int; 2020; 2020():3159482. PubMed ID: 32104686
[TBL] [Abstract][Full Text] [Related]
6. Strong Increase in Moxifloxacin Resistance Rate among Multidrug-Resistant Mycobacterium tuberculosis Isolates in China, 2007 to 2013.
Xia H; Zheng Y; Liu D; Wang S; He W; Zhao B; Song Y; Ou X; Zhou Y; van den Hof S; Cobelens F; Zhao Y
Microbiol Spectr; 2021 Dec; 9(3):e0040921. PubMed ID: 34851179
[TBL] [Abstract][Full Text] [Related]
7. Drug-Resistant Characteristics, Genetic Diversity, and Transmission Dynamics of Rifampicin-Resistant Mycobacterium tuberculosis in Hunan, China, Revealed by Whole-Genome Sequencing.
He W; Tan Y; Liu C; Wang Y; He P; Song Z; Liu D; Zheng H; Ma A; Zhao B; Ou X; Xia H; Wang S; Zhao Y
Microbiol Spectr; 2022 Feb; 10(1):e0154321. PubMed ID: 35171016
[TBL] [Abstract][Full Text] [Related]
8. Effect of the Xpert MTB/RIF on the detection of pulmonary tuberculosis cases and rifampicin resistance in Shanghai, China.
Wu Z; Rueda ZV; Li T; Zhang Z; Jiang Y; Sha W; Yu F; Chen J; Pan Q; Shen X; Yuan Z
BMC Infect Dis; 2020 Feb; 20(1):153. PubMed ID: 32070292
[TBL] [Abstract][Full Text] [Related]
9. Prevalence and factors associated with multidrug/rifampicin resistant tuberculosis among suspected drug resistant tuberculosis patients in Botswana.
Tembo BP; Malangu NG
BMC Infect Dis; 2019 Sep; 19(1):779. PubMed ID: 31492099
[TBL] [Abstract][Full Text] [Related]
10. Xpert
Kohli M; Schiller I; Dendukuri N; Dheda K; Denkinger CM; Schumacher SG; Steingart KR
Cochrane Database Syst Rev; 2018 Aug; 8(8):CD012768. PubMed ID: 30148542
[TBL] [Abstract][Full Text] [Related]
11. Principles of chemotherapy for tuberculosis in national tuberculosis programmes of low- and middle-income countries.
Chiang CY; Lin CJ
Indian J Tuberc; 2020 Dec; 67(4S):S16-S22. PubMed ID: 33308663
[TBL] [Abstract][Full Text] [Related]
12. [Study on the resistance of rifampicin-resistant Mycobacterium tuberculosis to anti-tuberculosis drugs in group A].
Dai XW; Li CY; Wang NH; Chen SS; Tian LL; Zhao YF; Tao LY; Yang XY; Ding BC; He XX
Zhonghua Jie He He Hu Xi Za Zhi; 2023 Nov; 46(11):1110-1117. PubMed ID: 37914422
[No Abstract] [Full Text] [Related]
13. Effect of Xpert MTB/RIF on the treatment of multi-drug-resistant or rifampicin-resistant tuberculosis screened out from re-treatment pulmonary tuberculosis patients, a prospective cohort study.
Wang P; Gu J; Yang J; Yang C; Wu X; Yu F; Fan L
Ann Palliat Med; 2020 Mar; 9(2):239-246. PubMed ID: 32233619
[TBL] [Abstract][Full Text] [Related]
14. Multidrug-resistant tuberculosis transmission among middle school students in Zhejiang Province, China.
Zhang Y; Zhou L; Liu ZW; Chai CL; Wang XM; Jiang JM; Chen SH
Infect Dis Poverty; 2020 May; 9(1):57. PubMed ID: 32460836
[TBL] [Abstract][Full Text] [Related]
15. Treatment outcomes of retreated patients with isoniazid/rifampicin resistant pulmonary tuberculosis.
Zhang L; Han X; Ge Q; Shu W; Sun Y; Gao J; Xie S; Wang J; Gao W
BMC Infect Dis; 2024 Jan; 24(1):7. PubMed ID: 38166793
[TBL] [Abstract][Full Text] [Related]
16. GeneXpert
Christopher PM; ; Widysanto A
Int J Mycobacteriol; 2019; 8(4):351-358. PubMed ID: 31793505
[TBL] [Abstract][Full Text] [Related]
17. Whole-genome sequencing for surveillance of fluoroquinolone resistance in rifampicin-susceptible tuberculosis in a rural district of Shanghai: A 10-year retrospective study.
Zhang Y; Jiang Y; Yu C; Li J; Shen X; Pan Q; Shen X
Front Public Health; 2022; 10():990894. PubMed ID: 36187694
[TBL] [Abstract][Full Text] [Related]
18. The Impact of COVID-19 Epidemic on Tuberculosis Reports Among Students - Guizhou Province, China, 2020.
He Y; Li T; Zhang L; Li R; Chen Z; Ruan Y; Su W; Li J
China CDC Wkly; 2022 Mar; 4(11):216-219. PubMed ID: 35433075
[TBL] [Abstract][Full Text] [Related]
19. Prevalence, associated factors and rifampicin resistance pattern of pulmonary tuberculosis among HIV-positive patients attending antiretroviral treatment clinic at East Gojjam Zone, Ethiopia: An institution-based cross-sectional study.
Toru M; Baye A; Gebeyehu Z; Abebaw A; Reta A
J Clin Tuberc Other Mycobact Dis; 2022 Dec; 29():100336. PubMed ID: 36405997
[TBL] [Abstract][Full Text] [Related]
20. Changing trend analysis on early detection of rifampicin resistant tuberculosis patients in southwestern area of China, 2016-2020.
Yang Y; Liu L; Yang X; Li L; Lu K; Chen J; Xu Z; Xu L
PLoS One; 2023; 18(11):e0280578. PubMed ID: 37971975
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
